Xarelto Manufacturers Face Lawsuit From Texas Woman
June 06, 2016 – – TheProductLawyers.com reports on Xarelto, a very popular blood thinner medication, and when it was initially released, it was unlike blood thinners before it in that it allowed greater flexibility to the patient. Today, however, after 5 years on the market, the drug is immersed in controversy, with over 3,400 lawsuits filed by users who claimed the drug caused excessive and uncontrollable internal bleeding. The thousands of lawsuits that have been filed are all against the same defendants, Bayer Healthcare and Janssen Pharmaceuticals (a subsidiary of Johnson and Johnson Corporation), the manufacturers of the drug. The cases allege very similar experiences that focus on uncontrollable bleeding precipitated from Xarelto’s use. In many cases, these bleeding episodes were fatal.
One lawsuit in particular focuses on the failure of Xarelto’s manufacturers to sufficiently warn patients of the potential risks associated with taking the drug.The lawsuit was filed by a couple in Texas in the Eastern District of New York, whose case is now part of the consolidated multidistrict litigation (MDL 2592) in Louisiana, which was approved by the U.S. Judicial Panel for Multidistrict Litigation (JPML).
The female complainant in this case was prescribed Xarelto by her doctor because she was at an increased risk of having a stroke due to atrial fibrillation. She claims that after only 5 months of taking the drug for her heart condition, she experienced a very quick onset of internal bleeding. She also states that because of the bleeding it has left her with some serious long-term health issues as well.
It should also be noted the number of new complaints and court filings has increased while those plaintiffs involved in the 3,400 already filed cases await their day in court to tell their stories and the stories of those who have died from excessive bleeding allegedly from using Xarelto.
The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.
###
Contact TheProductLawyers.com:
Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023
ReleaseID: 60010453